中华行为医学与脑科学杂志
中華行為醫學與腦科學雜誌
중화행위의학여뇌과학잡지
CHINESE JOURNAL OF BEHAVIORAL MEDICINE AND BRAIN SCIENCE
2009年
8期
716-717
,共2页
李万顺%崔宇%于晓东%贾杰芳%王爱祯
李萬順%崔宇%于曉東%賈傑芳%王愛禎
리만순%최우%우효동%가걸방%왕애정
丙戊酸镁缓释片%丙戊酸钠缓释片%躁狂发作
丙戊痠鎂緩釋片%丙戊痠鈉緩釋片%躁狂髮作
병무산미완석편%병무산납완석편%조광발작
Magnesium valprote extended action tablet%Sodium valproate sustained-release tablets%Manic episode
目的 比较丙戊酸镁缓释片与丙戊酸钠缓释片治疗躁狂发作的疗效及安全性.方法 采用入院顺序分层随机法,将60例躁狂发作的患者随机分为研究组(用丙戊酸镁缓释片系统治疗)与对照组(用丙戊酸钠缓释片系统治疗),疗程共3周,分别于治疗前、治疗后第1、第2、第3周末采用躁狂量表(BRMS)及副反应量表(TESS)分别评定疗效及不良反应.结果 研究组和对照组的BRMS评分在第1周末[分别为(21±3.6)分、(20±4.3)分]、第2周末[分别为(11±2.3)分、(12±3.5)分]、第3周末[分别为(6±1.7)分、(5±2.4)分]时比较,差异均无显著性(t=3.27~5.34,P=0.053~0.082).在第1周末,研究组的TESS评分[(3.12±2.37)分]显著低于对照组[(4.57±2.83)分],差异有显著性(t=3.58,P=0.002),而研究组和对照组的TESS评分在第2周末[分别为(2.95±2.26)分、(3.15±2.01)分]、第3周末[分别为(1.43±2.04)分、(1.72±2.31)分]比较,差异均无显著性(t=2.48~3.06,P=0.552~0.931).结论 丙戊酸镁缓释片具有疗效高,不良反应小等优点.
目的 比較丙戊痠鎂緩釋片與丙戊痠鈉緩釋片治療躁狂髮作的療效及安全性.方法 採用入院順序分層隨機法,將60例躁狂髮作的患者隨機分為研究組(用丙戊痠鎂緩釋片繫統治療)與對照組(用丙戊痠鈉緩釋片繫統治療),療程共3週,分彆于治療前、治療後第1、第2、第3週末採用躁狂量錶(BRMS)及副反應量錶(TESS)分彆評定療效及不良反應.結果 研究組和對照組的BRMS評分在第1週末[分彆為(21±3.6)分、(20±4.3)分]、第2週末[分彆為(11±2.3)分、(12±3.5)分]、第3週末[分彆為(6±1.7)分、(5±2.4)分]時比較,差異均無顯著性(t=3.27~5.34,P=0.053~0.082).在第1週末,研究組的TESS評分[(3.12±2.37)分]顯著低于對照組[(4.57±2.83)分],差異有顯著性(t=3.58,P=0.002),而研究組和對照組的TESS評分在第2週末[分彆為(2.95±2.26)分、(3.15±2.01)分]、第3週末[分彆為(1.43±2.04)分、(1.72±2.31)分]比較,差異均無顯著性(t=2.48~3.06,P=0.552~0.931).結論 丙戊痠鎂緩釋片具有療效高,不良反應小等優點.
목적 비교병무산미완석편여병무산납완석편치료조광발작적료효급안전성.방법 채용입원순서분층수궤법,장60례조광발작적환자수궤분위연구조(용병무산미완석편계통치료)여대조조(용병무산납완석편계통치료),료정공3주,분별우치료전、치료후제1、제2、제3주말채용조광량표(BRMS)급부반응량표(TESS)분별평정료효급불량반응.결과 연구조화대조조적BRMS평분재제1주말[분별위(21±3.6)분、(20±4.3)분]、제2주말[분별위(11±2.3)분、(12±3.5)분]、제3주말[분별위(6±1.7)분、(5±2.4)분]시비교,차이균무현저성(t=3.27~5.34,P=0.053~0.082).재제1주말,연구조적TESS평분[(3.12±2.37)분]현저저우대조조[(4.57±2.83)분],차이유현저성(t=3.58,P=0.002),이연구조화대조조적TESS평분재제2주말[분별위(2.95±2.26)분、(3.15±2.01)분]、제3주말[분별위(1.43±2.04)분、(1.72±2.31)분]비교,차이균무현저성(t=2.48~3.06,P=0.552~0.931).결론 병무산미완석편구유료효고,불량반응소등우점.
Objective To compare the efficacy and side effects f magnesium valprote extended action tab-let and sodium valproate sustained-release tablets in treatment of patients with mania. Methods A total of 60 pa-tients with mania randomly divided into two groups,study group with magnesium valprote extended action tablet and control group with sodium valpreate sustained-release tablets for treatment of three weeks. They were assessed and analysed contrastively using with Bech-Rafaeisen Mania Scale(BRMS) and Treatment Emergent Side Effect Scale (TESS) before treatment and in the Ist,2nd and 3rd weekend after treatment. Results There were no signifi-cantly differences between study group and control group for scores of BRMS in the I st (as follows :21±3.6,20 ± 4.3) ,2nd (as follows:11±2.3,12±3.5)and 3rd (as follows:6±1.7,5±2.4) weekend after treatment(t=3.27 ~5.34, P=0.053~0.082). In the 1st weekend of treatment,the total scores of TESS (3.12±2.37) in study group were significantly lower than those (4.57±2.83) in control group(t=3.58, P=0.002). There were no significantly differences between study group and control group for scores of TESS in the 2nd (as follows:2.95±2.26,3.15±2.01) and 3rd ( as follows: 1.43±2.04,1.72±2.31 ) weekend after treatment(t = 2.48~3.06, P = 0.552~0.931 ). Conclusion Magnesium valprote extended action tablet is effective in treating mania without severe side effects.